Literature DB >> 19952125

Diagnosis, management and therapeutic outcome in prepubertal Cushing's disease.

R P Dias1, A Kumaran, L F Chan, L Martin, F Afshar, M Matson, P N Plowman, J P Monson, G M Besser, A B Grossman, M O Savage, H L Storr.   

Abstract

OBJECTIVES: Cushing's disease (CD) in prepubertal children is very rare and presents important diagnostic and therapeutic challenges. We report experience of the management of this subpopulation of CD patients. STUDY DESIGN/
METHODS: Retrospective patient case note review.
RESULTS: Between 1985 and 2008, 17 prepubertal children (13M, 4F), aged 5.7-14.1 years presented to our centre for diagnosis and management of CD. All children had subnormal linear growth and excessive weight gain at presentation. A high proportion (85% of males, 75% of females) had evidence of excessive virilisation. Striae and hypertension were seen in 41% of patients. The investigation with highest sensitivity (100%) for CD was excessive increase of serum cortisol to i.v. CRH (mean increase 113%). Pituitary imaging performed in all the patients showed poor concordance with findings at surgery (31%). In contrast bilateral simultaneous inferior petrosal sinus sampling (BSIPSS), performed in 11/16 subjects showed a high correlation with surgical findings (91%). In 16 patients, transsphenoidal selective adenomectomy (TSS) achieved a cure rate of 44%. However, in the 11 patients who had pre-operative BSIPSS, the cure rate was 64%. Of the 16 patients, 9 patients who were not cured by TSS received external pituitary radiotherapy.
CONCLUSIONS: Prepubertal CD had distinctive features with increased frequency in males, abnormal auxology and excessive virilisation. The cortisol response to i.v. CRH administration was particularly exuberant and contributed to diagnosis. BSIPSS was much more helpful than pituitary imaging in localisation of the microadenoma and was associated with improved cure rate by TSS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19952125     DOI: 10.1530/EJE-09-0509

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  6 in total

Review 1.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

2.  Thyrotoxicosis in a 13-year-old girl following pituitary adenectomy for Cushing's disease.

Authors:  Arndis Audur Sigmarsdottir; Ingvar Hakon Olafsson; Ólafur Kjartansson; Ragnar Bjarnason
Journal:  Clin Case Rep       Date:  2017-07-06

3.  Cyclic Cushing's Disease in the Prepubertal Period-A Case Report and Review of Literature.

Authors:  Anna Wȩdrychowicz; Barbara Hull; Anna Kalicka-Kasperczyk; Grzegorz Zieliński; Jerzy B Starzyk
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-18       Impact factor: 5.555

4.  Mitotane (op'DDD) restores growth and puberty in nine children with Cushing's disease.

Authors:  Emmanuelle Motte; Anya Rothenbuhler; Stephan Gaillard; Najiba Lahlou; Cécile Teinturier; Régis Coutant; Agnès Linglart
Journal:  Endocr Connect       Date:  2018-12       Impact factor: 3.335

5.  Long-term outcome in patients after treatment for Cushing's disease in childhood.

Authors:  Katarzyna Pasternak-Pietrzak; Elżbieta Moszczyńska; Marcin Roszkowski; Karolina Kot; Elżbieta Marczak; Wiesława Grajkowska; Maciej Pronicki; Mieczysław Szalecki
Journal:  PLoS One       Date:  2019-12-12       Impact factor: 3.240

Review 6.  Paediatric Cushing's disease: Epidemiology, pathogenesis, clinical management and outcome.

Authors:  Rosario Ferrigno; Valeria Hasenmajer; Silvana Caiulo; Marianna Minnetti; Paola Mazzotta; Helen L Storr; Andrea M Isidori; Ashley B Grossman; Maria Cristina De Martino; Martin O Savage
Journal:  Rev Endocr Metab Disord       Date:  2021-01-30       Impact factor: 6.514

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.